The quality of antimalarial drugs in the Gabonese Republic (Central Africa).
Conditions
Interventions
n/a
(This is a prospective observational drug-quality field survey)
Sponsors
Academic Medical Centre (AMC)
Eligibility
Inclusion criteria
Inclusion criteria: Antimalarial drugs that will be purchased, collected and analyzed are: Amodiaquine; Artemether; Artesunate; Atovaquone; Chloroquine; dihydroartemisinin; Halofantrine; Lumefantrine; Mefloquine; Piperaquine; Primaquine; Proguanil; Pyrimethamine; Pyronaridine; Quinine; Sulfadoxine; Sulfamethoxypyrazine
Exclusion criteria
Exclusion criteria: n/a
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Quality of antimalarial drugs in Gabon. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Prevalence of poor quality antimalarial drugs. - Proportion of outlets selling poor quality medicines. - Prevalence/availability of antimalarial drugs that are no longer recommended as first or second line treatment in Gabon or by the World Health Organization (WHO). If possible: -Proportions of different types of poor quality medicines. - Risk indicators of poor quality antimalarial drugs. | — |
Contacts
Public ContactBenjamin Jelle Visser
Tropical Medicine Group Room A.01-342 Academic Medical Centre - University of Amsterdam Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon
Outcome results
None listed